Prostate Cancer - Results from #27740

Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment - Abstract June 13, 2011

Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: Findings at radical prostatectomy - Abstract June 13, 2011

Immunotherapy for the treatment of prostate cancer - Abstract June 13, 2011

Physical Activity after Diagnosis and Risk of Prostate Cancer Progression: Data from the Cancer of the Prostate Strategic Urologic Research Endeavor - Abstract June 13, 2011

Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomograms - Abstract June 13, 2011

Tracer kinetic model selection for dynamic contrast-enhanced computed tomography imaging of prostate cancer - Abstract June 13, 2011

AUA 2011 - Effect of long-acting testosterone injections for treatment of hypogonadism after brachytherapy for prostate cancer - Session Highlight by Doron S. Stember, MD June 13, 2011

Picking the optimal treatment for patients with metastatic castration resistant prostate cancer - Slide Presentation June 13, 2011

Abiraterone and increased survival in metastatic prostate cancer - Abstract June 12, 2011

A short-term cost-effectiveness study comparing robot-assisted laparoscopic and open retropubic radical prostatectomy - Abstract June 11, 2011

The contemporary concept of significant versus insignificant prostate cancer - Abstract June 10, 2011

A population-based study of prostate cancer chemotherapy - Abstract June 10, 2011

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21 - Abstract June 10, 2011

Current paradigms and evolving concepts in metastatic castration-resistant prostate cancer - Abstract June 10, 2011

From prostate to bone: Key players in prostate cancer bone metastasis - Abstract June 10, 2011

Rapid increase of the serum PSA level in response to high-intensity focused ultrasound therapy may be a potential indicator of biochemical recurrence of low- and intermediate-risk prostate cancer - Abstract June 10, 2011

Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer - Abstract June 10, 2011

Prostate cancer imaging: What surgeons, radiation oncologists, and medical oncologists want to know - Abstract June 10, 2011

The utility of 11C-choline PET/CT for imaging prostate cancer: A pictorial guide - Abstract June 10, 2011

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen - Abstract June 10, 2011

Page 1388 of 1437